Latest Related Publications

Transitioning to the 2021 optimal formulary for antiretroviral drugs for children: implementation considerations – WHO policy brief

On 16 July 2021, the World Health Organization (WHO) released its policy brief called “Transitioning to the 2021 optimal formulary for antiretroviral drugs for children: implementation considerations”, with the endorsement and/or support from a number of key organisations, including the Medicines Patent Pool. Access the Policy Brief

19 July 2021